Abstract
Disruption of the circadian clock as well as reduced NAD+ levels are both hallmarks of aging. While circadian rhythms and NAD+ metabolism have been linked in heart disease, their relationship during cardiac aging is less clear. Here, we show that aging leads to disruption of diurnal gene expression in the heart. Long-term supplementation with the NAD+ precursor nicotinamide riboside (NR) boosts NAD+ levels, reprograms the diurnal transcriptome and reverses naturally occurring cardiac enlargement in aged female mice. In addition, complete abolishment of NAD+ levels in CMs impairs PER2::luc oscillations, which is rescued by NR supplementation. These findings reveal an essential role for NAD+ in regulation of the cardiac circadian clock upon aging, which opens up new avenues to counteract age-related cardiac disorders.
Competing Interest Statement
The authors have declared no competing interest.
Abbreviations
- Ctrl
- control
- KO
- knock-out
- ZT
- Zeitgeber
- NAMPT
- nicotinamide phosphoribosyltransferase
- Adj.p
- Adjusted p-value
- FDR
- false discovery rate
- Anp
- Atrial natriuretic peptide
- Per2
- Period2
- Kcnn2
- Small conductance calcium-activated potassium channel protein 2
- Pak7
- P21-activated kinase 7
- Pfkfb2
- 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
- Tnfaip2
- tumor necrosis factor, alpha-induced protein 2
- Slc41a3
- solute carrier family 41, member 3
- Pde7a
- phosphodiesterase 7A
- Cpt1a
- carnitine palmitoyltransferase 1a
- Ppia
- peptidylprolyl isomerase A
- NAD+
- nicotinamide adenine dinucleotide
- NR
- nicotinamide riboside
- BVW
- biventricular weight
- BW
- body weight
